mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.004 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.004 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.005 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.005 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.005 |